UroGen Pharma Ltd.

NasdaqGM:URGN Stock Report

Market Cap: US$618.0m

UroGen Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:URGN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Mar 24SellUS$168,600Mark SchoenbergIndividual12,000US$14.05
01 Feb 24SellUS$78,790Jason SmithIndividual4,993US$15.78
01 Feb 24SellUS$59,790Mark SchoenbergIndividual3,789US$15.78
28 Jul 23BuyUS$15,000,000Monograph Capital PartnersCompany1,572,327US$9.54

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of URGN?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1870.000518%
General Public1,340,5223.71%
Individual Insiders2,322,9036.43%
VC/PE Firms5,703,97515.8%
Hedge Funds5,827,17316.1%
Institutions20,935,36157.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 75.5%.


Top Shareholders

Top 25 shareholders own 84.08% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.02%
RTW Investments, LP
3,257,347US$55.7m88.6%0.91%
8.53%
RA Capital Management, L.P.
3,083,430US$52.7m0%0.71%
7.25%
Great Point Partners, LLC
2,620,545US$44.8m0%8.35%
7.11%
Point72 Asset Management, L.P.
2,569,826US$44.0m130%0.09%
6.37%
Menora Mivtachim Pensions & Gemel Ltd.
2,303,031US$39.4m0%0.23%
4.97%
Cowen Inc,Private Banking and Investment Banking Investments
1,796,589US$30.7m10.5%0.97%
4.62%
BlackRock, Inc.
1,669,543US$28.6m-2.75%no data
4.35%
Monograph Capital Partners
1,572,327US$26.9m0%no data
4.12%
Pontifax Venture Capital
1,487,669US$25.4m0%9.99%
3.79%
Moshe Arkin
1,369,315US$23.4m0%no data
3.6%
Adage Capital Management, L.P.
1,300,000US$22.2m0%0.04%
3.32%
Credit Suisse Asset Management (Switzerland) Ltd.
1,200,000US$20.5m0%0.02%
2.32%
Jefferies Financial Group Inc.,Asset Management Arm
840,000US$14.4m0%0.35%
1.9%
Migdal Mutual Funds Ltd.
686,472US$11.7m5.89%0.1%
1.86%
Harel Insurance Investments and Finances Services Ltd, Asset Management Arm
673,487US$11.5m-22.6%0.14%
1.49%
State Street Global Advisors, Inc.
536,994US$9.2m9.41%no data
1.41%
Silverarc Capital Management, LLC
508,587US$8.7m-3.2%2.84%
1.37%
Wildcat Capital Management, LLC
495,606US$8.5m0%1.8%
1.13%
Medical Strategy GmbH, Asset Management Arm
409,713US$7.0m-3.81%0.4%
1.13%
Arie Belldegrun
408,693US$7.0m0%no data
1.05%
Morgan Stanley, Investment Banking and Brokerage Investments
380,342US$6.5m-14.5%no data
0.9%
Elizabeth Barrett
326,941US$5.6m0%no data
0.9%
Geode Capital Management, LLC
323,952US$5.5m3.66%no data
0.8%
Superstring Capital Management LP
288,267US$4.9m12.9%4.37%
0.75%
Opaleye Management Inc.
270,000US$4.6m-15.6%1.11%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.